Crossmark

Who currently benefits from the aetiological treatment for Chagas disease?

Crossref DOI link: https://doi.org/10.1016/j.eimce.2018.04.012

Published Print: 2018-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Molina Romero, Israel

Sulleiro Igual, Elena
License Information

Text and Data Mining valid from 2018-08-01
More Information

This article is maintained by: Elsevier

Article Title: Who currently benefits from the aetiological treatment for Chagas disease?

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2018.04.012

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2018.04.005

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.